Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Nausea × Dronabinol × Clear all

Phase

Phase 3 1 Phase 2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Parasomnias 1 Pain 1 Nausea 1 Marijuana Abuse 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 Cancer Pain 1 Breast Neoplasms 1 Anxiety Disorders 1

Interventions

Aprepitant 11 Palonosetron 9 Dexamethasone 9 Ondansetron 7 Olanzapine 5 Calcium Dobesilate 4 netupitant 2 fosaprepitant 2 Tropisetron 2 Radiotherapy 2 Fluorouracil 2 yangzheng xiaoji 1 rolapitant 1 ramosetron 1 niraparib 1 netupitant, palosentron drug combination 1 nabiximols 1 isatuximab 1 ginger extract 1 dolasetron 1 casopitant 1 Therapeutics 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Radiation 1 Paclitaxel 1 Oxaliplatin 1 Octreotide 1 Midazolam 1 Lorazepam 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03948074 2025-09-10

CAFCARS

British Columbia Cancer Agency

Phase 2 Completed

Anxiety Disorders, Nausea, Pain, Parasomnias

Data powered by HemOnc (CC BY 4.0) Colophon ⚡